Retail squeeze · 46 dossiers

The July 15-16 $1B convertible plus the slip of initial commercial direct-to-device service into 2027 broke the "2H26 revenue" leg the June rebound was built on; a 17% one-day flush to $55.01 and a fading +12% bounce mark this as a…

The gov-capital quantum leg has broken. IONQ lost the $44 spring base and then $40, is on a seven-week losing streak and ~36% off its June level, as Wolfpack's Pentagon-earmark thesis reasserted and Morgan Stanley cut its stake below 5%.…

Bitcoin-treasury flywheel is mathematically shut: basic mNAV 0.62x (7/6) means issuing equity now destroys BTC-per-share, and Strategy raised $467M on 7/13 while buying zero bitcoin. Capital funds a 12% STRC coupon and a $3B reserve…

The policy leg is done: QBTS lost the $20 shelf on 2026-07-13 and sits near $16.70, -29.4% MTD and ~64% off the $46.75 high, with the whole quantum cohort printing lower lows and inverse quantum ETFs up to +108%. Sell-side still carries a…

The $10 shelf broke: QUBT closed $7.80 on 2026-07-17, market cap down to ~$1.76B on $4.33M TTM revenue, while the quantum basket de-rated on a risk-off tape. Early-July authorization to 450M shares plus a $118.52M/13.54M-share registration…

Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the…

The gamma-squeeze/index leg is over: PURR is -42% from its 6/1 high of $11.62 to $6.68 (7/17), through the $7.70 shelf, and now trades at roughly 0.78x the value of its 17.6M HYPE stack a treasury premium that has flipped to a discount,…

Box-office recovery drew its first sell-side nod Macquarie lifted its PT to $2 (Neutral) on 2026-07-08 and price is stabilizing above the 200-day MA. But a Neutral target sitting at the $2 shelf implies no upside; ~1B shares and ~$4B net…

Bitcoin-treasury premium fully inverted: Strive keeps buying (19,882 BTC as of July 2, latest lot @ $59,850) into record BTC ETF outflows while mNAV sits at a ~0.78x discount, so the $2.55B ATM now destroys NAV per share. Peer treasury…

Fully re-rated small-cap CPaaS squeeze: +360% YoY to ~$75, ~5% under the $79.08 high. The mid-June $275M 0% convert broke above its $72.64 strike instead of capping the tape. Riley lifted its target to $85 on 2026-07-09 but price has…

The May earnings-miss squeeze has fully round-tripped the ~39% pop off the 2026-05-06 Q2 print has bled to the mid-$30s (~$33.77, 07-10 close), below the ~$36 gap base, as BEAD revenue slips to FY2027 and insiders sell into the plan. The…

Court-ordered 4.5-Star recalc (2026-06-10, +18.9%) is a spent binary that gapped CLOV above its $4.23 52-week high, with no company catalyst until the ~early-August Q2 print. The 2026-07-06 Elevance copycat suit shows the Star-rating…

Citi Trends' value-apparel turnaround is real and accelerating Q1 FY2026 comps +13.9%, a 21-month positive streak, and a raised full-year guide but the 2026-06-02 print was the catalyst and it fired five weeks ago. On an ~8.1M-share float…

Deleveraging-and-refranchising turnaround with a now-dated catalyst: Q2 FY2026 prints 2026-08-06. Net leverage cut to ~5.5x from 6.7x, liquidity >$300M, but revenue still shrinks and ~23-29% of the float is short. The tradeable energy is a…

Closed-end SpaceX proxy whose entire bull case the pre-IPO scarcity premium is now dead: SpaceX trades publicly (SPCX, $135 IPO 2026-06-12, ran to $225, back near ~$145 lows by 2026-07-10). DXYZ's premium has collapsed from ~151% (May)…

Data-center-power narrative intact, but the June re-rating just met a $225M equity raise (10.71M sh at $21.00, July 8) that capped the move; a Siemens design/supply partnership (July 9) stabilized the tape, yet a fresh entry near $21…

Post-dilution CNS microcap re-firing with the psychedelic cohort (ATAI, CMPS all moving 2026-07-16) after a June social-velocity blowoff and a 10.3M-share secondary at $4.85. Both covering shops cut targets in July while holding Buy. No…

GLP-1 reaccel is a promise until the ~2026-08-10 Q2 print the first proof of the +25-28% guide off a +4% Q1 trough. Sell-side has now chased above spot (Canaccord $40, Barclays $39, BofA $37), so upgrade fuel is largely spent, CVS entering…

Squeeze fuse defused and now the tape confirms it: after the 06-25 raise cleared 37M shares at $2.70, HTZ printed a death cross (07-06) and Morgan Stanley cut to $3.50. Jane Street's new 5.0% stake is convertible-arb inventory, not…

Halted micro-cap: the $39.49 last print (June 8, 2026) was a 3,660% blow-off from $1.05 on a $3M AI 'used-phone sales agent' deal, after which Nasdaq froze it under T12 and the board opened a probe into its own trading. No live tradeable…

June's move was a float mechanic Russell Microcap inclusion (effective 2026-06-30) into a 40%-short float drove $8.92 to $18.13, and it is unwinding ($14.98 on 2026-07-17, -7.76%). SSS is genuinely inflecting (-6.7% → -3.8%), but price…

Genuine FY2026 turnaround (loss→$3.6M net, record $166M rev) plus a +20–22% Q1 guide drove a +36% circuit-breaker gap on 2026-06-15. Three weeks on the catalyst is spent, no fresh news since June 18, RSI-88.6 momentum has bled off the gap…

Squeeze leg has stalled: Morgan Stanley's 2026-07-06 Underweight/$15 reinit broke the one-way upgrade cluster and knocked the stock -5.9% on 07-08. Price ~$17.18 still holds above the 50- and 200-day, but with the sell-side now two-sided…

Q1 FY27 (2026-06-11) beat in a shrinking furniture category, but the tape refused the news and no volume-confirmed reclaim has fired five weeks on. With ~27–31% short float and clustered June insider buys, the only live edge is a squeeze…

The June 30 NASA Moon BASE award ($148.3M Nova-C) bought exactly one green session before the stock broke: seven straight down days into 2026-07-13 for -24.5%, -36.5% on the month, $13.80 on 2026-07-18 versus a $38.55 May high. A live…

De-risked Wilson-disease NDA melt-up extended rather than sold the EAN news: a 6.70M-share float ran to fresh all-time highs (~$111 on 2026-07-17) on the June-30 FDA Rare Pediatric Disease designation and clustered analyst PT hikes. The…

Sympathy bid off the Micron-led memory supercycle and Russell 2000 inclusion floored the post-parabola markdown in the low-$20s, but the ~2026-07-28 Q2 print is now the binary: Everspin must show a non-casino datacenter/AI design win or…

Re-rating leg has stalled: NUTX closed $162.98 on 2026-07-17 after five straight down days, ~20% off the $204.00 high, giving back the June breakout that B. Riley's 2026-06-26 Buy/$290 initiation topped out. A $55.0M true-up of 18,950…

Drone theme re-accelerated on AVAV's 2026-06-30 Q4 blowout; ONDS stacked the ~$875.8M DZYNE deal (07-06) and raised FY2026 guidance to ≥$525M but registered 39,999,998 resale shares the same day. Heavy short interest plus repeat whale call…

Flow-plus-squeeze trade into a fixed date: Russell 3000 inclusion (effective after close 2026-06-26) stacked on a 13.3%-of-float short base and the CEO warrant short-trap, against a deteriorating iBuyer (Q1 rev -38% YoY, Q2 guide ~20%…

Squeeze leg broke: +43% in four sessions to a $63.79 high, then management priced 3.62M shares at $55.22 (~8% discount) and closed ~$191.9M net on 2026-07-06. Price round-tripped to $37.04, under the 20- and 50-day and under the $49…

Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM…

The +475% hydrogen-comeback squeeze has broken: the $3.12 Q1 gap and the 50-day both failed, price is ~$2.17 (-20% in 30d), and Susquehanna cut its target $3.75 → $2.50 on 2026-07-10. The June 30 NY Gateway close resolved as a restructure…

Profitable e-commerce-acceleration hypergrowth (Q1'26 rev +43%, NRR 127%) that went parabolic off the June Russell inclusion; now ~20% above the $22.88 average analyst target and overbought into the 2026-08-05 Q2 print. The narrative…

The eFPGA/defense royalty squeeze has fully unwound: QUIK is ~$13, roughly 47% below the $24.33 June high, and the $18 shelf broke exactly as the Russell inclusion passed. July's post-quantum IP announcement drew no bid good news into no…

Post-SpaceX-IPO space deflation has broken every support: RDW lost the ~$10.40 July shelf and prints ~$8.51, ~67% below the 5/28 record close. The $500M ATM is now ~59M shares (~25% of float) versus ~27M at its $18.57 June reference…

Highest-beta space-narrative small-cap (~+496% YTD, 15.6% short) whose dominant SpaceX-IPO catalyst sold off (2026-06-12, -11.44%). Rocket Lab's $8B Iridium deal (2026-06-29) re-fired the theme, but SATL is a sub-scale, GAAP-unprofitable…

Russell-add passive bid printed and faded after the 2026-06-26 close, and SpaceX now trades publicly (SPCX), gutting the proxy premium; SIDU has round-tripped to ~$2.16 from the $5.08 offering with an active short campaign and no dated…

A record short squeeze (~32% of float) and buyout speculation, now joined by sell-side PT hikes (Alliance Global $10→$25, Jul 17), have carried SLS to a $16 test and back to ~$13; the defining Phase 3 REGAL overall-survival readout stays…

Dilution leg has broken the story: the $7B raise cleared at $27.50 on June 11 and spot is $24.18, with a live $2B ATM as forward supply. DDR contract prices +32% QoQ crush a business guiding 8.2–8.4% gross margin. Falling knife under all…

Tariff/de-minimis "secondhand wins" narrative that drove a ~$2→$12 run has matured into a show-me story; stock rolled to ~$7 with analyst PTs being cut, and the 2026-08-03 Q2 print is the binary on whether AI-first marketplace and the new…

Panagiotidis shipping shell (NOT lawnmower TTC) ran 1.93→8.50 on a sub-NAV/special-dividend story that is now fully paid out and closed. Six weeks of dead tape since the 2026-06-05 payout ($3.8M cash + 5,707,246 NEW shares); on a true…

The Novo squeeze is fully round-tripped and the funding answer arrived on 2026-07-02: a $21.8M at-the-market program via Oppenheimer/Canaccord. At $2.42 (07-15) that is ~9M shares against ~16M outstanding the company will now sell stock…

April's YATOP squeeze (+56% to $1.77) has fully round-tripped; YAAS prints $0.731 (2026-07-02) at fresh lows below the prior $0.7503 floor. A live $6.36M Aegis ATM (filed 2026-06-26) now sells into every bounce while a re-armed Nasdaq…